Immune response precision customized to tumor adaptive kinetics

Area of Science:

• Computational biology
• Cancer immunology
• Theoretical oncology

Background:

• Tumor heterogeneity, arising from accumulated mutations, challenges adaptive immune responses.
• High phenotypic diversity in tumors can lead to immune evasion, reducing treatment efficacy.

Purpose of the Study:

• To investigate the conditions under which tumor heterogeneity facilitates immune evasion.
• To evaluate the impact of different immune activation strategies on tumor clearance rates.

Main Methods:

• Developed an agent-based model simulating individual cancer cells with vector-represented phenotypes.
• Modeled mutation as a random walk in phenotypic space.
• Assessed immune activation by modulating affinity thresholds and tumor clearance rates.

Main Results:

• The model demonstrated oscillatory behavior, potentially driven by negative frequency-dependent selection.
• Increased variance in cancer phenotypes correlated with tumor population collapse.
• Identified specific conditions favoring narrow or broad immune activation profiles.

Conclusions:

• Tumor heterogeneity plays a critical role in immune evasion.
• Findings suggest optimizing immunotherapies by matching immune cell priming to tumor adaptive dynamics.
• Tailoring antigenic repertoires could enhance the efficacy of treatments like adoptive cell therapy.